Novavax se convierte en la cuarta vacuna contra el COVID-19 autorizada por la FDA

28 Julio: Novavax está disponible en Oregón. El pasado 13 de julio, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) autorizó el uso de emergencia de la vacuna contra el COVID-19 Novavax para adultos mayores de 18 años. La vacuna Novavax es diferente de las otras tres […]

Novavax becomes fourth COVID-19 vaccine authorized by FDA

Available in Spanish Update 7/28: Novavax is available in Oregon. Yesterday, July 13, the U.S. Food and Drug Administration (FDA) authorized for emergency use the COVID-19 vaccine Novavax for adults age 18 and older. The Novavax vaccine is different from the other three vaccines available in the United States. It does not use mRNA technology […]

New medication approved for prevention of COVID-19 in certain adults and children

On Dec. 8, 2021, the Food and Drug Administration (FDA) authorized AstraZeneca’s Evusheld under emergency use for prevention of COVID-19 infection in certain adults and children. Evusheld is a long-acting monoclonal antibody therapy.

FDA panel endorses first antiviral treatment for COVID-19

Today, an expert panel of the Food and Drug Administration (FDA) endorsed the use of the Merck antiviral drug molnupiravir for treatment of symptomatic COVID-19 in test-confirmed patients with high risk conditions. The FDA has not yet authorized the treatment.

Oregón se prepara para posible aprobación del uso de dosis de refuerzo para las vacunas de Moderna y Johnson & Johnson

Oregón se prepara para recibir la aprobación del uso de dosis de refuerzo para las vacunas Moderna y Johnson & Johnson, si la Administración de Medicamentos y Alimentos de los Estados Unidos (FDA, por sus siglas en inglés) modifica su acta de Uso de Emergencia, y si los Centros para el Control y Prevención de Enfermedades (CDC, por sus siglas en inglés), así como el Grupo de Trabajo de Revisión de Seguridad Científica de los Estados de los estados del Oeste, recomiendan su uso.

Oregon prepares for possible federal decisions to authorize COVID-19 booster shots for Moderna and Johnson & Johnson vaccines

Oregon will be ready to make booster shots available to eligible persons who had previously received the Moderna and Johnson & Johnson COVID-19 vaccines, should the U.S. Food and Drug Administration (FDA) amend its Emergency Use Authorizations and the Centers for Disease Control and Prevention (CDC) and the Western States Scientific Safety Review Workgroup recommend their use.

Medical and public health experts determine when to recommend a booster

Medical and public health experts determine when to recommend a booster. This week, the U.S. Food and Drug Administration (FDA) will consider whether to recommend that individuals who were vaccinated with Johnson & Johnson and Moderna COVID-19 vaccines should get booster doses.

How federal decisions on COVID-19 vaccines make their way to Oregon consumers

On Oct. 7, 2021, Pfizer and BioNTech asked the Food and Drug Administration (FDA) to authorize emergency use of their COVID-19 vaccine for children ages 5 to 11. So when can children under age 12 in Oregon be vaccinated? The answer depends on how long it takes for the decision to make its way through the process to authorize vaccinations in Oregon.

El OHA publica una declaración sobre la recomendación de dosis de refuerzo

Hoy, los funcionarios de la Administración de Alimentos y Medicamentos (FDA) se reunieron con expertos médicos para discutir si recomendar que las personas que previamente han sido vacunadas por completo con la vacuna contra el COVID-19 de Pfizer, reciban una inyección de refuerzo para ayudar a mantener la efectividad de sus vacunas durante tiempo. En […]

OHA releases statement on booster dose recommendation

Today, officials from the Food and Drug Administration (FDA) convened medical experts to discuss whether to recommend that people who’ve previously been fully vaccinated with the Pfizer COVID-19 vaccine should receive a booster shot to help maintain the effectiveness of their vaccinations over time. At today’s hearing, the committee recommended that people age 65 and […]